Key result
Among 10 children treated for Ewing sarcoma at a single center in Singapore, multimodality treatment yielded an overall and event-free survival rate of 88.9% at a median follow-up of 3.1 years.
In a small single-center Asian cohort of pediatric Ewing sarcoma, contemporary chemotherapy protocols combined with local control yielded an 88.9% overall and event-free survival.
Dear Editor, Ewing sarcoma is a malignant mesenchymal tumour that presents as a bone or soft-tissue sarcoma. Translocations involving the EWS gene on chromosome 22q12 are unique molecular signatures.1,2 Compared with the West where the annual incidence is 1–3 per million, incidence has been reported to be lower among Asians1 and in East Asia.3 Paediatric-specific
No takes yet. Share an insight, caveat, or question.
Lee et al. (2021) conducted a letter in Ewing sarcoma (n=10). Multimodality treatment (Euro-E.W.I.N.G. or COG protocols) was evaluated on Overall and event-free survival. Among 10 children treated for Ewing sarcoma at a single center in Singapore, multimodality treatment yielded an overall and event-free survival rate of 88.9% at a median follow-up of 3.1 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: